India is close to agreeing to grant foreign COVID-19 vaccine makers such as Pfizer Inc protection against legal liability so that it can use their shots in an immunisation campaign that is facing acute shortages, three government sources told Reuters. "Indemnity will be granted," said one of the sources. India invited Pfizer, Moderna and Johnson & Johnson in April to sell their vaccines after infections rocketed.
The Serum Institute of India has sought regulatory approval to make Russia's Sputnik V COVID-19 vaccine, local media reported on Thursday, on top of the AstraZeneca PLC and Novavax Inc shots it is already producing.
NEW DELHI (Reuters) - The Serum institute of India will raise production of the AstraZeneca COVID-19 vaccine to about 90 million doses in June from ab.
India accelerates vaccine supplies in fight against COVID-19 by Reuters
Monday, 31 May 2021 10:30 GMT
About our Humanitarian Crises coverage From major disaster, conflicts and under-reported stories, we shine a light on the world’s hotspots
Share:
By Krishna N. Das and Neha Arora
NEW DELHI, May 31 (Reuters) - India s Serum Institute will increase production of AstraZeneca COVID-19 vaccines by nearly 40% in June, officials said on Monday, in the first step towards alleviating a shortage that has worsened the country s battle with coronavirus.
The world s second most-populous nation has struggled with a catastrophic outbreak of COVID-19 since last month which is only now starting to abate after killing tens of thousands of people.